<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04386278</url>
  </required_header>
  <id_info>
    <org_study_id>RI.2</org_study_id>
    <nct_id>NCT04386278</nct_id>
  </id_info>
  <brief_title>OrthoPulse Gen 2 Initial Device Evaluation and Assessment of Clinical Effectiveness (CA)</brief_title>
  <official_title>RI.2 OrthoPulse Gen 2 Initial Device Evaluation and Assessment of Clinical</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biolux Research Holdings, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biolux Research Holdings, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, interventional, non-randomized, control, split-mouth, open-label,
      single centre, private practice study aimed to evaluate the effect of tooth movement during
      orthodontic treatment using a removeable thermoplastic orthodontic appliance. Intrusion and
      extrusion will be conducted using bilaterally equivalent elastomeric forces of 50 grams.

      A comparison of the rate of bilateral orthodontic tooth movement will be conducted using six
      (6) varied photobiomodulation interventions on the maxillary (upper) and mandibular (lower)
      arches. The OrthoPulse Gen 2 and OrthoPulse (commercially approved) devices are being used in
      this clinical investigation. Each subject enrolled will go through intrusion and extrusion.

      All subjects will be allocated to an OrthoPulse split-mouth intervention by the investigator.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2020</start_date>
  <completion_date type="Anticipated">August 8, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 8, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Each group in this study includes a different device iteration that is being investigated in parallel.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The rate of orthodontic tooth movement</measure>
    <time_frame>36 days (±12 days) from T0 visit</time_frame>
    <description>The rate of orthodontic tooth movement during intrusion at 36 days (±12 days) from the T0 Visit (measured in mm per week).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peak Pain: Questionnaire</measure>
    <time_frame>7 Days</time_frame>
    <description>Assess peak pain experienced over first seven (7) days of treatment during intrusion using a questions similar in nature to a Visual Analog Scale (subject to complete pain questionnaire).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Root Resorption</measure>
    <time_frame>36 days (±12 days) from T0 visit</time_frame>
    <description>Assess tooth resorption by measuring the root length of the first or second bicuspid bilaterally from baseline to T3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Initial Safety of Device</measure>
    <time_frame>From enrolment to study completion, anticipated six (6) months</time_frame>
    <description>Confirmation of safety through collection of adverse events</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Orthodontic Tooth Movement</condition>
  <arm_group>
    <arm_group_label>Intervention 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Side one: No treatment Side two: OrthoPulse Gen 2 (2RP) for one minute</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for one minute</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for 5 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RCW) for five minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention 6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for five minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention 7</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention 8</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for five minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intervention 1</intervention_name>
    <description>Side one: No treatment Side two: OrthoPulse Gen 2 (2RP) for one minute</description>
    <arm_group_label>Intervention 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intervention 2</intervention_name>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for one minute</description>
    <arm_group_label>Intervention 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intervention 3</intervention_name>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for 5 minutes</description>
    <arm_group_label>Intervention 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intervention 4</intervention_name>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RCW) for five minutes</description>
    <arm_group_label>Intervention 4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intervention 5</intervention_name>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute</description>
    <arm_group_label>Intervention 5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intervention 6</intervention_name>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for five minutes</description>
    <arm_group_label>Intervention 6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intervention 7</intervention_name>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute</description>
    <arm_group_label>Intervention 7</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intervention 8</intervention_name>
    <description>Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RBP) for five minutes</description>
    <arm_group_label>Intervention 8</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient must be 19 years of age or older

          -  Likely to be compliant to OrthoPulse use, aligner wear, and Dental Monitoring scanning

          -  Have a compatible iOS or Android device and are willing to download the OrthoPulse and
             Dental Monitoring apps for frequent automatic syncing of data

        Exclusion Criteria:

          -  Patient is currently enrolled in another clinical study

          -  Crowding or rotations of bilateral bicuspids that would prevent or interfere with
             intrusion

          -  Periodontally involved teeth, acute oral infection or periodontal disease

          -  Patient has active/untreated caries

          -  Use of bisphosphonates at any time

          -  Use of drugs that may cause photosensitivity

          -  History of photosensitivity

          -  Epilepsy

          -  Pregnant or planning pregnancy during the study.

          -  Patient plans to relocate over the treatment period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dr. Peter Brawn</name>
      <address>
        <city>Vancouver</city>
        <state>B.C</state>
        <zip>V6A 4G8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nichola Kosloski</last_name>
      <phone>778-588-7339</phone>
      <email>nichola@drpeterbrawn.ca</email>
    </contact>
    <contact_backup>
      <last_name>Clea Owens</last_name>
      <phone>778-588-7339</phone>
      <email>c.owens@bioluxresearch.com</email>
    </contact_backup>
    <investigator>
      <last_name>Peter Brawn</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 8, 2020</study_first_submitted>
  <study_first_submitted_qc>May 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2020</study_first_posted>
  <last_update_submitted>May 8, 2020</last_update_submitted>
  <last_update_submitted_qc>May 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

